Streetbeat News

Revenues

EVH

Evolent Health (NYSE:EVH) has received mixed analyst ratings, with a recent positive shift in average price targets. Analysts have provided a range of price targets from $31.00 to $45.00, with an average of $38.29, up 4.3% from the previous average. The company has shown strong revenue growth and financial health metrics, despite a negative net margin.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 3:00 pm

AIT

Applied Industrial Techs (NYSE:AIT) has significantly outperformed the market over the past 15 years, with an annualized return of 17.49%. A $1000 investment in AIT 15 years ago would now be worth $11,341.16, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 3:00 pm

B

Barnes Group Inc (NYSE:B) has received mixed analyst ratings over the past three months, with a recent average price target of $46.25, reflecting a 7.56% increase from the previous target. Analysts have adjusted their ratings and price targets in response to market conditions, with some raising and others lowering their expectations. Despite positive revenue growth, Barnes Gr faces challenges with profitability, return on equity, and debt management.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 3:00 pm

GDDY

GoDaddy (NYSE:GDDY) has delivered an impressive annualized return of 20.3% over the past 5 years, outperforming the market by 6.22%. A $100 investment in GDDY 5 years ago would now be worth $253.51, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 3:00 pm

AAPL

The article provides an in-depth analysis of Apple Inc. (NASDAQ:AAPL) compared to its competitors in the Technology Hardware, Storage & Peripherals industry. It highlights Apple's high valuation metrics (P/E, P/B, P/S) suggesting overvaluation, but also notes its strong profitability indicators like ROE, EBITDA, and gross profit. However, Apple's revenue growth is significantly lower than the industry average.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 3:00 pm

FBIN

Analysts have varied ratings for Fortune Brands (NYSE:FBIN), with a mix of bullish and indifferent sentiments. Recent price targets average $85, up from $81.62, with a high of $98 and a low of $79. The company shows positive revenue growth but faces challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 3:00 pm

BP

SLB

XOM

Energy stocks are declining due to easing Middle East tensions and uncertainty over China's economic stimulus, affecting demand outlook.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:48 pm

WYNN

Wynn Resorts shares fell by 2.97% due to a major selloff in Chinese markets, driven by disappointment over the lack of bold fiscal stimulus from the Chinese government. This raises concerns about the recovery of Macau's gaming sector, where Wynn generates significant revenue.

Portfolio Pulse from Henry Khederian

October 08, 2024 | 2:43 pm

ACB

CGC

TLRY

Canopy Growth Corp. (NASDAQ:CGC) is focusing on a 'brand-first' strategy through its Canopy USA entity, which includes brands like Wana and Jetty. Analyst Pablo Zuanic suggests this positions Canopy for growth, especially with potential federal regulatory changes. Canopy's asset-light approach contrasts with Canadian peers like Tilray and Aurora, focusing on brand expansion rather than cultivation.

Portfolio Pulse from Nicolás Jose Rodriguez

October 08, 2024 | 2:38 pm

GK

MSOS

Investor Ross Gerber highlights the potential growth in the cannabis and music festival industries, estimating a $50B-$60B annual opportunity in the U.S. He notes the current market cap of Canadian public cannabis companies is $10B-$15B, with a $200B-$300B growth potential.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:33 pm